Families caring for individuals with Duchenne muscular dystrophy (DMD) face significant financial burdens from necessary home ...

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from ...

After months of uncertainty and controversy, the FDA has given approval to Sarepta's Duchenne muscular dystrophy drug – even though it hasn't yet shown any proof it can slow progress of the ...

Swiss biotech Santhera has found a North American partner for its Duchenne muscular dystrophy (DMD) therapy vamorolone, ahead of an FDA decision on the drug due by 26th October. Florida-based rare ...

We use cookies and similar technologies to provide our services and to measure and improve your experience. If you choose ‘Accept’, the online marketing you see about ITV will be more relevant to you.

A research team collected pain and prescription data from the medical records of 1,282 people with different types of ...